Jia Jie Biomedical Co Ltd (4109) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jia Jie Biomedical Co Ltd (4109) has a cash flow conversion efficiency ratio of 0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$11.32 Million ≈ $356.71K USD) by net assets (NT$1.71 Billion ≈ $54.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4109 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Jia Jie Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Jia Jie Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jia Jie Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jia Jie Biomedical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Autech Corporation
KQ:067170
|
-0.009x |
|
Cofix Group Ltd
TA:CFX
|
0.532x |
|
Tinka Resources Limited
V:TK
|
-0.006x |
|
Universal Textile Co Ltd
TW:1445
|
0.037x |
|
Bengang Steel Plates Co Ltd
SHE:200761
|
-0.062x |
|
Comtrend Corp
TWO:8089
|
0.105x |
|
Kairous Acquisition Corp Ltd
NASDAQ:KACL
|
-0.008x |
|
Bonia Corporation Bhd
KLSE:9288
|
0.021x |
Annual Cash Flow Conversion Efficiency for Jia Jie Biomedical Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Jia Jie Biomedical Co Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 4109 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.71 Billion ≈ $54.00 Million |
NT$21.34 Million ≈ $672.42K |
0.012x | -61.83% |
| 2024-12-31 | NT$1.36 Billion ≈ $42.82 Million |
NT$44.35 Million ≈ $1.40 Million |
0.033x | +878.02% |
| 2023-12-31 | NT$1.07 Billion ≈ $33.72 Million |
NT$-4.49 Million ≈ $-141.40K |
-0.004x | +55.86% |
| 2022-12-31 | NT$923.96 Million ≈ $29.11 Million |
NT$-8.78 Million ≈ $-276.56K |
-0.010x | -303.12% |
| 2021-12-31 | NT$934.93 Million ≈ $29.46 Million |
NT$4.37 Million ≈ $137.77K |
0.005x | -84.33% |
| 2020-12-31 | NT$907.97 Million ≈ $28.61 Million |
NT$27.10 Million ≈ $853.80K |
0.030x | -16.07% |
| 2019-12-31 | NT$694.88 Million ≈ $21.89 Million |
NT$24.71 Million ≈ $778.56K |
0.036x | +293.94% |
| 2018-12-31 | NT$714.19 Million ≈ $22.50 Million |
NT$-13.10 Million ≈ $-412.60K |
-0.018x | +6.56% |
| 2017-12-31 | NT$699.60 Million ≈ $22.04 Million |
NT$-13.73 Million ≈ $-432.54K |
-0.020x | +75.32% |
| 2016-12-31 | NT$962.54 Million ≈ $30.33 Million |
NT$-76.54 Million ≈ $-2.41 Million |
-0.080x | -195.08% |
| 2015-12-31 | NT$983.23 Million ≈ $30.98 Million |
NT$82.22 Million ≈ $2.59 Million |
0.084x | -- |
About Jia Jie Biomedical Co Ltd
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more